LACTAMKINASEINHIBITOREN

European patent · EP3216792 · Deleted

Register entry

Publication number
EP3216792
Application number
EP17155466
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 27, 2013
Published
Sep 13, 2017
Granted
May 27, 2020
Deleted
Oct 29, 2021
Reason
Annual fee unpaid
IPC classes
C07D 487/14 (2006.01)
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
A61P 29/00 (2006.01)
Priority
US 201261617657 P 29.03.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 29, 2021

    Deleted, fee unpaid

    Published in Swissreg on 29.10.2021

  2. May 27, 2020

    Granted

    Published in Swissreg on 27.05.2020

Parties

Holder

G1 Therapeutics, Inc.

700 Park Offices Drive, Suite 200, Research Triangle Park, NC 27709, US

Inventor

TAVARES, Francis Xavier

Durham, North Carolina 27713-1903, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.